ClinicalTrials.Veeva

Menu

Observational Study on Endometrial Stromal Tumors (EST)

I

Italian Sarcoma Group

Status

Enrolling

Conditions

Endometrial Stromal Tumors

Treatments

Other: Treatment for EST

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02829437
ISG EST

Details and patient eligibility

About

Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

Full description

Observational, retrospective and prospective study on EST aimed to understand more about its biology, natural history and antitumor activity of different treatment options.

This study will collect data in prospective and retrospective way of patients affected by EST and treated according disease guidelines and local practices.

The study will also review the diagnosis by a central expert pathologist in order to its confirmation

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014
  • Informed consent signature

Exclusion criteria

  • patients with different diagnosis from EST

Trial design

100 participants in 2 patient groups

Retrospective Observational Group
Description:
Patients who received treatment for EST Patients with EST diagnosis prior August 2016
Treatment:
Other: Treatment for EST
Prospective Observational Group
Description:
Patients who will receive treatment for EST Patients with EST diagnosis after August 2016
Treatment:
Other: Treatment for EST

Trial contacts and locations

13

Loading...

Central trial contact

Gianluca Ignazzi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems